Studying gut bacteria in people with inflammatory bowel disease
Observes gut bacteria and related features in Korean patients with inflammatory bowel disease.
Key facts
- Who runs it
- Kyunghee University Medical Center
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- Gut Microbiome in Inflammatory Bowel Disease
- Status
- Recruiting
- People taking part
- 1,500 people, planned
- Started
- 1 Apr 2018
- Expected to end
- 31 Mar 2028
- Type of study
- Observational
- Record updated
- 10 March 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with an established diagnosis of inflammatory bowel disease, either ulcerative colitis or Crohn disease.
- Sex
- Women and men can join.
- Disease stage
- An established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease.
- Earlier treatment
- People who used antibiotics or probiotics within the previous 2 weeks cannot join.
Main reasons for not taking part
- Used antibiotics within the previous 2 weeks
- Used probiotics within the previous 2 weeks
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Patients with established diagnosis of inflammatory bowel disease, including ulcerative colitis and Crohn disease
Who cannot take part
- Person with history of using antibiotics or probiotics within previous 2 weeks
Where in South Korea
- Kyung Hee University HospitalSeoul, South KoreaContact: Chang Kyun Lee, MD, PhDTaking people
About the trial
What the trial wants to find out
Inflammatory bowel disease (IBD) is a chronic inflammatory condition for gastrointestinal tract. There have been numerous studies to reveal dysbiosis of fecal/mucosal microbiome composition in IBD patients but actual trend of dysbiosis is strikingly different among patient's ethnicity.
Read full original descriptionShow less
In this background, the investigators have composed a prospective cohort of Korean IBD patients in a large academic referral IBD center. Using an integrated multi-omics bioinformatic analysis, the investigators aim to explore gut microbial signatures along with distinct clinical/genetic features, and their potential interplay in patients with IBD.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Discovery of Gut Microbial Signatures in Inflammatory Bowel Disease
- Plain-language title
- Studying gut bacteria in people with inflammatory bowel diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Record updated
- 10 March 2023